- Convenient nasal swab specimens
- Fast results in 15 minutes
- Excellent performance compared to molecular PCR methods
- Room temperature storage
- Meets and exceeds WHO criteria
- Used by NHS trusts
The performance of Flowflex SARS-CoV-2 Antigen Rapid Test was established with 304 nasal swabs collected from individual symptomatic patients (within 7 days of onset) who were suspected of COVID-19. The performance of the Flowflex SARS-CoV-2 Antigen Rapid Test was compared to a RTPCR method.